Allison C Rosenthal (Allison Rosenthal)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Venues

American journal of hematology

Current treatment options in oncology

Current oncology reports

Leukemia & lymphoma

Mayo Clinic Hospital

Utah State University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Hospital Jan 1o 2016

United States

Consultant :: Hematology Medical Oncology

Education History

Utah State University Jul 1o 1999 - Jun 30o 2004

United States

BSC

Publications

Scott F Huntington, Stephen J Schuster, Wei Ding, Amber B Koehler, Danielle M Brander, Allison C Rosenthal, Jose F Leis, Han W Tun, Muhamad Alhaj Moustafa, Madiha Iqbal, Wei He, Albert S Kearney, Timothy P McKinlay, Min Gui, Anthony R Mato
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: an open-label, multicenter, phase 1a/1b study. American journal of hematology (2023)
Scott F Huntington, Stephen J Schuster, Wei Ding, Amber B Koehler, Danielle M Brander, Allison C Rosenthal, Jose F Leis, Han W Tun, Muhamad Alhaj Moustafa, Madiha Iqbal, Wei He, Albert S Kearney, Timothy P McKinlay, Min Gui, Anthony R Mato
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study. American journal of hematology (2023)
Allison C Rosenthal, Adam S DuVall, Justine M Kahn, Niloufer Khan
Disparities in care and outcomes for adolescent and young adult lymphoma patients. EJHaem 4 (4) (2023)
Omran Saifi, Scott C Lester, William G Breen, William G Rule, Yi Lin, N Nora Bennani, Allison C Rosenthal, Javier Munoz, Hemant S Murthy, Mohamed A Kharfan-Dabaja, Jennifer L Peterson, Bradford S Hoppe
Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach. American journal of hematology (2023)
Allison C Rosenthal
Quality of Life and Survivorship in Lymphoma. Current oncology reports 24 (9) (2022)
Anagha Deshpande, William Rule, Allison C Rosenthal
Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas. Current treatment options in oncology 23 (1) (2022)
Caitlin M Brumfiel, Meera H Patel, David J DiCaudo, Allison C Rosenthal, Mark R Pittelkow, Aaron R Mangold
Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination. Leukemia & lymphoma 62 (10) (2021)
Emily Galloway, Melody Griffith, Allison C Rosenthal
Multidisciplinary Management of Adolescent and Young Adult Patients with Hodgkin Lymphoma. Current treatment options in oncology 22 (7) (2021)
Jithma A Abeykoon, Saurabh Zanwar, Stephen M Ansell, Eli Muchtar, Rong He, Patricia T Greipp, Rebecca L King, Sikander Ailawadhi, Jonas Paludo, Jeremy T Larsen, Thomas M Habermann, David J Inwards, Ronald S Go, Gita Thanarajasingam, Francis Buadi, Angela Dispenzieri, Carrie A Thompson, Thomas E Witzig, Martha Lacy, Wilson I Gonsalves, Grzegorz S Nowakowski, David Dingli, Sundararajan Vincent Rajkumar, Robert A Kyle, Taimur Sher, Vivek Roy, Allison C Rosenthal, Asher A Chanan-Khan, Craig Reeder, Morie A Gertz, Shaji K Kumar, Prashant Kapoor
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemia. American journal of hematology 96 (8) (2021)
Talal Hilal, Zhen Wang, Diana Almader-Douglas, Allison C Rosenthal, Craig B Reeder, Tania Jain
Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta-analysis. American journal of hematology 93 (10) (2018)
Priyanka A Pophali, Andrew Ip, Melissa C Larson, Allison C Rosenthal, Matthew J Maurer, Christopher R Flowers, Brian K Link, Umar Farooq, Andrew L Feldman, Cristine Allmer, Susan L Slager, Thomas E Witzig, Thomas M Habermann, Jonathon B Cohen, James R Cerhan, Carrie A Thompson
The association of physical activity before and after lymphoma diagnosis with survival outcomes. American journal of hematology 93 (12) (2018)
Allison C Rosenthal, Amylou C Dueck, Stephen Ansell, Katherine Gano, Christopher Conley, Grzegorz S Nowakowski, John Camoriano, Jose F Leis, Joseph R Mikhael, A Keith Stewart, David Inwards, David Dingli, Shaji Kumar, Pierre Noel, Morie Gertz, Luis Porrata, Stephen Russell, Joseph Colgan, Rafael Fonseca, Thomas M Habermann, Prashant Kapoor, Francis Buadi, Nelson Leung, Rodger Tiedemann, Thomas E Witzig, Craig Reeder
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy. American journal of hematology 92 (5) (2017)

Allison C Rosenthal.css-eqlu8i{font-size:small;padding-left:4px;} (Allison Rosenthal)

Publication Activity (10 Years)

Top Topics

Top Venues

Allison C Rosenthal (Allison Rosenthal)